Technical Analysis for NVLN - Novelion Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 1.2 -4.76% -0.06
NVLN closed down 4.76 percent on Monday, March 18, 2019, on 65 percent of normal volume.

Earnings due: Mar 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical NVLN trend table...

Date Alert Name Type % Chg
Mar 18 Fell Below 20 DMA Bearish 0.00%
Mar 18 Bollinger Band Squeeze Range Contraction 0.00%
Mar 18 Calm After Storm Range Contraction 0.00%
Mar 15 Shooting Star Candlestick Bearish -4.76%
Mar 15 Lizard Bearish Bearish Day Trade Setup -4.76%
Mar 15 Crossed Above 20 DMA Bullish -4.76%
Mar 15 Pocket Pivot Bullish Swing Setup -4.76%
Mar 15 Volume Surge Other -4.76%
Mar 15 Bollinger Band Squeeze Range Contraction -4.76%
Mar 15 Wide Range Bar Range Expansion -4.76%

Older signals for NVLN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Rare Diseases Retinal Disease
Is NVLN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.79
52 Week Low 0.7
Average Volume 416,011
200-Day Moving Average 2.1882
50-Day Moving Average 1.1336
20-Day Moving Average 1.239
10-Day Moving Average 1.225
Average True Range 0.0975
ADX 20.92
+DI 35.5829
-DI 18.8173
Chandelier Exit (Long, 3 ATRs ) 1.2275
Chandelier Exit (Short, 3 ATRs ) 1.3225
Upper Bollinger Band 1.3438
Lower Bollinger Band 1.1342
Percent B (%b) 0.31
BandWidth 16.916868
MACD Line 0.0198
MACD Signal Line 0.0278
MACD Histogram -0.008
Fundamentals Value
Market Cap 22.38 Million
Num Shares 18.6 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 1.11
Price-to-Book 1.08
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.32
Resistance 3 (R3) 1.32 1.29 1.30
Resistance 2 (R2) 1.29 1.26 1.29 1.29
Resistance 1 (R1) 1.24 1.24 1.27 1.24 1.29
Pivot Point 1.21 1.21 1.22 1.21 1.21
Support 1 (S1) 1.16 1.18 1.19 1.16 1.11
Support 2 (S2) 1.13 1.16 1.13 1.11
Support 3 (S3) 1.08 1.13 1.10
Support 4 (S4) 1.08